New Articles
  September 7th, 2015 | Written by

MNX Global Logistics opens new Life Sciences Logistics Center in Amsterdam

[shareaholic app="share_buttons" id="13106399"]


  • MNX Logistics facility was designed to exceed standards in the handling of pharma and medical device shipments.
  • MNX CEO: Demand for biologics, cold chain and medical devices logistics has seen double digit growth.
  • Life Sciences Logistics Center in Amsterdam allows MNX to provide cross docking, inventory storage and transportation.

MNX Global Logistics announced last week the opening of its dedicated supply chain and logistics facility in Amsterdam, the Netherlands, located just outside of Amsterdam Schiphol Airport. The facility will serve as the operations and warehousing hub for MNX’s life sciences and medical device customers throughout Europe.

The capacity of the new facility, with validated temperature-controlled supply chain capabilities, is around 14,000 square feet with the option to expand by an additional 18,000 square feet. The facility was designed to exceed the highest standards in the handling and movement of biopharmaceutical, radiopharmaceutical and medical device shipments. The facility features -20 degrees C, 2-8 degrees C and 18 degrees C temperature controlled storage with 24/7 monitoring, back-up systems and state of the art security in order to ensure the constant integrity and security of our customer’s temperature and high value shipments.

“The demand for our services particularly in biologics, cold chain and medical devices logistics in the EMEA region has been tremendous and we have seen double digit growth in the past 12 months,” said Paul J. Martins, MNX CEO and President. “Customers with the need for expertise in regulatory transport, strict adherence to chain of custody, visibility, control and security of their high value and time critical products are turning more and more to MNX. Our investment in this new facility in Amsterdam is testament to MNX and our private equity partner, The Riverside Company’s commitment to meet the needs and exceed the expectations of our customers.”

Utilizing a dedicated facility at Amsterdam will allow MNX to provide staff with the ability to comply with the strictest standards for packaging, inventory, cross dock, storage and transportation for our customer’s shipments.

“The new Life Sciences Logistics Centre in Amsterdam allows us to provide cross docking, inventory storage and transportation for our clients needing temperature sensitive control,” said Jan Willem Van ‘t Riet, MNX Senior Vice President for EMEA. “In addition, our customers will benefit from our strict adherence to industry wide compliance procedures and protocols and our direct ramp access to personally deliver and retrieve critical shipments from the airlines that serve Amsterdam Airport Schiphol.”

MNX provides of specialized logistics services to the aviation, life science, and medical device sectors, among others.